Printer Friendly
The Free Library
14,800,529 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

TEVA GETS FIRST FDA APPROVAL OF KETOCONAZOLE 2% CREAM.


Teva Pharmaceutical Industries Teva Pharmaceutical Industries Ltd. (Hebrew: טבע תעשיות פרמצבטיות בע"מ), NASDAQ: TEVA is an international pharmaceutical company headquartered in  Ltd. (NASDAQ NASDAQ
 in full National Association of Securities Dealers Automated Quotations

U.S. market for over-the-counter securities. Established in 1971 by the National Association of Securities Dealers (NASD), NASDAQ is an automated quotation system that reports on
:TEVA), Jerusalem, has received from the US Food and Drug Administration an approval to manufacture and market Ketoconazole ketoconazole /ke·to·co·na·zole/ (ke?to-kon´ah-zol) a derivative of imidazole used as an antifungal agent.

ke·to·co·na·zole
n.
 2% Cream. Teva USA has launched the product.

Ketoconazole 2% Cream is Teva's generic version of Janssen's anti-fungal drug Nizoral(R) 2% Cream, of which annual US sales are approximately $65 million.

Teva views this approval as significant as it is the first approval for a generic version of this drug. Unlike most oral dosage forms A dosage form is the physical form of a dose of medication, such as a capsule or injection. The route of administration is dependent on the dosage form of a given drug. , this product required a 325 patient, 18 center, double-blinded, three-way, placebo controlled clinical study to demonstrate bio-equivalence.

Teva Pharmaceutical Industries Limited is Israel's largest pharmaceutical company, with over 80% of its sales outside Israel mainly in the United States United States, officially United States of America, republic (2005 est. pop. 295,734,000), 3,539,227 sq mi (9,166,598 sq km), North America. The United States is the world's third largest country in population and the fourth largest country in area. . The company develops, manufactures, and markets generic and branded human pharmaceuticals and active pharmaceutical ingredients.

Corporate Headquarters are at 5 Basel St., P.O. Box 3190, Petah Tiqva 49131, Israel; Tel: 972-3-9267267, Fax: 972-3-9234050.

For more information, call (215)256-8400.
COPYRIGHT 2000 Worldwide Videotex
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2000, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Title Annotation:Teva Pharmaceutical Industries Ltd.
Comment:TEVA GETS FIRST FDA APPROVAL OF KETOCONAZOLE 2% CREAM.(Teva Pharmaceutical Industries Ltd.)
Publication:Worldwide Biotech
Article Type:Brief Article
Geographic Code:7ISRA
Date:Jun 1, 2000
Words:158
Previous Article:AMERICAN BIOMED REPORTS PROGRESS IN COMMERCIALIZATION.(Brief Article)
Next Article:IMMTECH ESTABLISHING CONSORTIUM TO TREAT LEISHMANIASIS.(Brief Article)
Topics:



Related Articles
TEVA PHARMACEUTICAL INDUSTRIES, LIMITED RESPONDS TO "HAARAETZ" NEWSPAPER ARTICLE.
Teva Pharmaceutical Industries Ltd. says Copaxone to be presented to September FDA advisory panel.
Teva receives FDA approvable letter for Copaxone.
Teva Pharmaceutical Industries Ltd. Announces 1998 Third Quarter and Nine Month Financial Results; Declares Regular Quarterly Cash Dividend -.
Teva Pharmaceutical Industries Ltd. Comments On Israeli Press Report.
Teva Pharmaceutical Receives First FDA Approval of Ketoconazole 2% Cream.
Teva Pharmaceutical Industries LTD Receives Final FDA Approval of Nabumetone 750mg; 180 Days Market Exclusivity Under Paragraph IV.
Teva Modernizes It's Board Structure.
TEVA SIGNS PACT TO BUY HONEYWELL PHARMACEUTICAL IN ITALY.
FDA APPROVES TEVA'S ANDA TO MARKET GENERIC VERSION OF ZOCOR.

Terms of use | Copyright © 2010 Farlex, Inc. | Feedback | For webmasters | Submit articles